These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13221661)

  • 1. Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.
    ROWE GG; HUSTON JH; MAXWELL GM; CROSLEY AP; CRUMPTON CW
    J Clin Invest; 1955 Jan; 34(1):115-20. PubMed ID: 13221661
    [No Abstract]   [Full Text] [Related]  

  • 2. The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine.
    FREIS ED; ROSE JC; HIGGINS TF; FINNERTY FA; KELLEY RT; PARTENOPE EA
    Circulation; 1953 Aug; 8(2):199-204. PubMed ID: 13067200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of hydrazinophthalazine on intrarenal hemodynamics in essential hypertension].
    DOERING P; KOCH R; KUHNS K; SCHWAB M
    Dtsch Arch Klin Med; 1954; 201(1):44-56. PubMed ID: 13173294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies on the effects of the hypotension provoking hydrazinophthalazine derivatives apresoline and nepresol on blood circulation].
    BEIN HJ; GROSS F; TRIPOD J; MEIER R
    Schweiz Med Wochenschr; 1953 Apr; 83(14):336-40. PubMed ID: 13076043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hydrazinophthalazine on arterial pressure in hypertension].
    PLESCH SA; CAPRIS TA
    Prensa Med Argent; 1953 Apr; 40(15):882-4. PubMed ID: 13073889
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effects of 1-hydrazinophthalazine in the dog, with special reference to circulating splanchnic blood volume.
    MARKS PA; REYNELL PC; BRADLEY SE
    Am J Physiol; 1955 Oct; 183(1):144-8. PubMed ID: 13268652
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake and jugular oxygen tension in hypertensive subjects.
    HAFKENSCHIEL JH; FRIEDLAND CK
    J Clin Invest; 1953 Jul; 32(7):655-60. PubMed ID: 13069612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arterial hypertension with hydrazinophthalazine derivatives].
    ABAZA A; VARROUD-VIAL J
    Bull Mem Soc Med Hop Paris; 1953 May 29-Jun 5; 69(17-18):530-49. PubMed ID: 13082401
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of oral 1-hydrazinophthalazine therapy on renal function in essential vascular hypertension.
    MADER IJ; ISERI L
    Am Heart J; 1955 Oct; 50(4):556-66. PubMed ID: 13258483
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial hypertension: the therapeutic effect of sodium restriction combined with 1-hydrazinophthalazine or dibenzyline.
    GILL RJ; DUNCAN GG; REINHARDT DJ
    Am J Med Sci; 1953 Sep; 226(3):249-60. PubMed ID: 13080265
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined 1-hydrazinophthalazine and Rauwolfia serpentina in therapy of arterial hypertension].
    FAERCHTEIN I; GINEFRA P
    Med Cir Farm; 1955 May; 229():163-72. PubMed ID: 13244050
    [No Abstract]   [Full Text] [Related]  

  • 12. Further cardiovascular and renal hemodynamic studies following the administration of hydralazine (1-hydrazinophthalazine) and the effect of ganglionic blockade with hexamethonium on these responses.
    MOYER JH; HUGGINS RA; HANDLEY CA
    J Pharmacol Exp Ther; 1953 Oct; 109(2):175-82. PubMed ID: 13097349
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of 1-hydrazinophthalazine upon coronary hemodynamics and myocardial oxygen metabolism in essential hypertension.
    ROWE GG; HUSTON JH; MAXWELL GM; WEINSTEIN AB; TUCHMAN H; CRUMPTON CW
    J Clin Invest; 1955 May; 34(5):696-9. PubMed ID: 14367526
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hypotensive drugs on stroke volume and vascular resistance in hypertension. II. Reserpin (Serpasil-Ciba) and its combination with Nepresol].
    SCHUMANN H
    Klin Wochenschr; 1954 Mar; 32(9-10):220-4. PubMed ID: 13153088
    [No Abstract]   [Full Text] [Related]  

  • 15. [1-Hydrazinophthalazine hydrochloride in the treatment of hypertension].
    PICCINELLI O
    Farmaco Sci; 1953; 8(5):294-302. PubMed ID: 13095495
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of hydrazinophthalazine in essential hypertension].
    VIZZINI AA
    Hospital (Rio J); 1953 Dec; 44(6):775-82. PubMed ID: 13151634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hydrazinophthalazine in hypertension; clinical studies].
    ESSELLIER AF; LUSCHER W; MORANDI L
    Schweiz Med Wochenschr; 1953 Apr; 83(14):340-5. PubMed ID: 13076044
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-Hydrazinophthalazine (apresoline) in hypertension.
    HARRIS E; TURNER R
    Lancet; 1954 Feb; 266(6809):429-33. PubMed ID: 13131873
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal and hypotensive effects of acute and chronic oral treatment with 1-hydrazinophthalazine (apresoline) in hypertension.
    VANDERKOLK K; DONTAS AS; HOOBLER SW
    Am Heart J; 1954 Jul; 48(1):95-101. PubMed ID: 13171330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hypertension with hydrazinophthalazine].
    KUHNS K; MEYER-HOFMANN G; HOPFNER K
    Klin Wochenschr; 1953 Aug; 31(29-30):690-4. PubMed ID: 13097882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.